Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

USFDA approves Sun Pharmaceutical's ANDA to market Rilutek tablets

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted a tentative approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Sanofi Aventis's Rilutek® tablets 50 mg.

29 Sep 2010

Optogenetics helps to restore optimal movement in people with physical disabilities

Researchers at Stanford University were able to use light to induce normal patterns of muscle contraction, in a study involving bioengineered mice whose nerve-cell surfaces are coated with special light-sensitive proteins.

28 Sep 2010

Women's mental health issues to be discussed at 2010 Marc- Society International Conference

Nearly 500 researchers, clinicians and mental health advocates are expected to attend the 2010 Marc- Society International Conference, Perinatal Mental Health Research: Harvesting the Potential, Oct. 26 to 30, at the Sheraton Station Square Hotel in Pittsburgh. The event, which focuses on women's mental health issues related to childbearing, will feature keynote speaker former First Lady Rosalynn Carter, who has been an active advocate for mental health reform.

28 Sep 2010

USC, Las Encinas Hospital to study on schizophrenia, bipolar disorder in younger, older adults

Schizophrenia and bipolar disorder affect 3% to 4% of the world's population, or about 222 million adults worldwide. In the United States, bipolar disorder affects about 5.7 million adult Americans 18 and older. Bipolar disorder, or manic depression, is a serious brain disorder that causes extreme shifts in mood, energy and functioning. People with the disorder experience episodes of mania and depression that can last from days to months. These symptoms usually begin in late adolescence, but can begin in early childhood or as late as a person's 40s or 50s. There is a strong genetic component related to bipolar disorder.

28 Sep 2010

MediciNova receives FDA approval to proceed with initial trial of ibudilast

MediciNova Inc, a biopharmaceutical company publicly traded on the NASDAQ Global Market and the Hercules Market of the Osaka Securities Exchange (Code Number:4875), today reported FDA's approval to proceed with an initial trial of the company's neurological drug candidate, ibudilast (MN-166/AV411), as a potential new pharmacotherapy for methamphetamine addiction.

27 Sep 2010

People with Parkinson's disease have high levels of beta-HCH pesticide

People with Parkinson's disease have significantly higher blood levels of a particular pesticide than healthy people or those with Alzheimer's disease, researchers at UT Southwestern Medical Center have found.

27 Sep 2010

Mayo Clinic initiates enrollment in first U.S. clinical Hand Transplant Program

Mayo Clinic has initiated the first clinical Hand Transplant Program in the United States and is now enrolling patients. This program offers hand transplantation as a clinically available option for patients with bilateral hand injuries or amputations. This allows patients to embark on this option of reconstructive surgery without being required to enroll in experimental trials.

24 Sep 2010

Concerted effort yields significant progress in reducing depression, HIV/AIDS, and osteoporosis in women

A concerted effort to boost research on women's health over the last two decades has lessened the burden of disease and reduced deaths among women due to cardiovascular disease, breast cancer, and cervical cancer, says a new report from the Institute of Medicine. The effort has yielded less but still significant progress in reducing the effects of depression, HIV/AIDS, and osteoporosis on women, added the committee that wrote the report.

24 Sep 2010

MTHFD1L gene may increase risk of developing late-onset Alzheimer's disease

Researchers have identified a gene that appears to increase a person's risk of developing late-onset Alzheimer's disease, the most common form of the disease. The gene, abbreviated as MTHFD1L, is on chromosome six, and was identified in a genome-wide association study.

24 Sep 2010

Many antisocial boys may have malfunctioning brains

Antisocial boys who abuse drugs, break laws, and act recklessly are not just "bad" kids. Many of these boys may have malfunctioning brains, according to a new study by researchers at the University of Colorado School of Medicine.

24 Sep 2010

UC researcher receives NIDA’s Avant-Garde Award for cocaine addiction research

A University of Cincinnati (UC) researcher will receive $2.5 million over five years from the National Institute on Drug Abuse (NIDA) to support his work on a potential immunotherapy for cocaine addiction.

22 Sep 2010

Dr. Shlomo Melmed awarded 9th Endocrine Regulation Prize of the Fondation Ipsen

The international jury under the presidency of Professor Iain Robinson (National Institute for Medical Research, London, UK) awarded today the 9th Endocrine Regulation Prize of the Fondation Ipsen (20.000€) to Dr. Shlomo Melmed (Cedars-Sinai Medical Center, Los Angeles, USA) during the annual congress of the ENEA (European NeuroEndocrine Association) in Liège (Belgium), for his translational approach to endocrinology. Shlomo Melmed is an internationally recognized endocrinologist and an authority on pituitary medicine.

22 Sep 2010

Sun Pharma completes acquisition of controlling stake in Taro

Sun Pharmaceutical Industries Ltd. today announced that it has completed the acquisition of a controlling stake in Taro Pharmaceutical Industries Ltd. pursuant to the Option Agreement entered into in 2007 with Taro's controlling shareholders led by Taro's Chairman, Dr. Barrie Levitt.

22 Sep 2010

ADI releases World Alzheimer Report 2010

The World Alzheimer Report 2010 was released today to mark World Alzheimer's Day and heighten awareness of the global economic impact of Alzheimer's disease and related dementias.

21 Sep 2010

Ginkgo-special extract improves mental performance of dementia patients

In a systematic review, known as a meta-analysis, a group of scientists at the University of Shanghai has demonstrated yet again that Ginkgo-special extract EGb 761 significantly improves the mental performance of dementia patients (Wang et al., 2010). A particular feature of this review was that, for the first time, researchers incorporated the risk of further deterioration of mental performance due to the natural progress of the disease into their assessment.

21 Sep 2010

Haven Behavioral Hospital offers treatment programs for adults with psychiatric illnesses

Haven Behavioral Hospital of Eastern Pennsylvania announced today it is offering acute intensive, inpatient and partial day treatment programs for adults with major psychiatric illnesses. The hospital will operate within the downtown campus of St. Joseph Medical Center and will offer services for adults suffering from schizophrenia, bipolar disorder, depression and anxiety disorders.

21 Sep 2010

Global action needed to address 'most significant health crisis of the 21st century'

A landmark report on the Global Economic Impact of Dementia finds that Alzheimer's disease and other dementias are exacting a massive toll on the global economy, with the problem set to accelerate in coming years. The World Alzheimer Report 2010 - issued on World Alzheimer's Day by Alzheimer's Disease International (ADI) - provides the most current and comprehensive global picture of the economic and social costs of the illness.

21 Sep 2010

Danya International unveils new website for autism spectrum disorders

Danya International, Inc. (Danya), a communications, research, and technology company, unveils the new AutismOnline.com Web site encompassing research-based products and resources for individuals of all ages with autism spectrum disorders (ASD). The AutismOnline.com Web site was introduced during a launch event today at the historic AFI Silver Theatre and Cultural Center in Silver Spring, Maryland.

21 Sep 2010

Dominion validates clinical urine drug monitoring assay to detect metabolites of 'herbal incense' product compounds

Dominion Diagnostics has recently developed and validated one of the first clinical urine drug monitoring assays to detect the metabolites of JWH-018 and JWH-073, two compounds typically found in synthetic cannabinoids, also referred to as "herbal incense" products.

20 Sep 2010

UCLA conference to provide information about latest developments to help enhance quality of life of seniors

While aging impacts everyday living in many ways, the latest technologies in the medical, consumer and lifestyle fields have the potential to help older adults live better for longer.

18 Sep 2010

Psychiatry News and Research

Further Reading

USFDA approves Sun Pharmaceutical's ANDA to market Rilutek tablets

Optogenetics helps to restore optimal movement in people with physical disabilities

Women's mental health issues to be discussed at 2010 Marc- Society International Conference

USC, Las Encinas Hospital to study on schizophrenia, bipolar disorder in younger, older adults

MediciNova receives FDA approval to proceed with initial trial of ibudilast

People with Parkinson's disease have high levels of beta-HCH pesticide

Mayo Clinic initiates enrollment in first U.S. clinical Hand Transplant Program

Concerted effort yields significant progress in reducing depression, HIV/AIDS, and osteoporosis in women

MTHFD1L gene may increase risk of developing late-onset Alzheimer's disease

Many antisocial boys may have malfunctioning brains

UC researcher receives NIDA’s Avant-Garde Award for cocaine addiction research

Dr. Shlomo Melmed awarded 9th Endocrine Regulation Prize of the Fondation Ipsen

Sun Pharma completes acquisition of controlling stake in Taro

ADI releases World Alzheimer Report 2010

Ginkgo-special extract improves mental performance of dementia patients

Haven Behavioral Hospital offers treatment programs for adults with psychiatric illnesses

Global action needed to address 'most significant health crisis of the 21st century'

Danya International unveils new website for autism spectrum disorders

Dominion validates clinical urine drug monitoring assay to detect metabolites of 'herbal incense' product compounds

UCLA conference to provide information about latest developments to help enhance quality of life of seniors

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News